Author: Branden

“You always get what you screen for” At a recent Bits ‘n Bio meetup, I met Akhila Kosaraju, M.D. Akhila is CEO and co-founder of Phare Bio, a nonprofit working with the Collins Lab at MIT on AI-driven antibiotic discovery, including predictive screening and generative design. AI can dramatically change the scale and speed at…

I had the opportunity to attend Catalent’s Covering Every Base in Clinical Supply summit this week in San Diego. The event included updates on their OneHub platform, a tour of the Miramar campus, and discussions with the teams supporting early-phase clinical programs. A few observations stood out. Clinical supply depends on more than manufacturing. Catalent’s…

Portal Instruments Brings the Star Trek Hypospray Closer to Reality Watching CEO Patrick Anquetil demonstrate the device live, I immediately thought of Dr. McCoy’s hypospray from Star Trek. Many biologics are becoming more concentrated because patients want fewer injections. High-viscosity formulations create entirely new engineering challenges. In other cases, the dose volume exceeds the capabilities…